Endpoints News 28. Feb. 2026 Merck looks to expand Welireg label following combo readouts with Keytruda, Lenvima
Endpoints News 28. Feb. 2026 GLP-1 news galore; Top 100 venture investors; Doug Ingram to step down; and more
Endpoints News 27. Feb. 2026 US International Trade Commission to take a closer look at Chinese biotech
Endpoints News 27. Feb. 2026 Merck cuts more than 150 jobs at new Gardasil vaccine plant in North Carolina
Endpoints News 27. Feb. 2026 Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design
Endpoints News 27. Feb. 2026 Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
Endpoints News 26. Feb. 2026 Doug Ingram’s force of will meets its match as Sarepta CEO plans to depart
Endpoints News 26. Feb. 2026 Boehringer wins accelerated approval for first-line use of lung cancer drug